Cartesian Therapeutics (RNAC) Times Interest Earned (2015 - 2023)
Cartesian Therapeutics (RNAC) reported Times Interest Earned of -$10.26 for Q3 2023, down 414.76% year-over-year from $3.26 in Q3 2022, and up 58.59% quarter-over-quarter from -$24.78 in Q2 2023.
Cartesian Therapeutics (RNAC) Times Interest Earned (2015 - 2023) Analysis & Trends
Cartesian Therapeutics (RNAC) has 9 years of Times Interest Earned data on file, last reported at -$10.26 in Q3 2023.
- Times Interest Earned for Q3 2023 came in at -$10.26, down 414.76% year-over-year; the trailing twelve-month figure through Jun 2024 was -$38.48 (down 158.84% YoY), and the FY2023 annual result was -$30.5, down 735.96% from the prior year.
- Times Interest Earned grew to -$10.26 in Q3 2023 per RNAC's latest filing, from -$24.78 in the prior quarter.
- Over five years, Times Interest Earned peaked at $19.38 in Q2 2022 and troughed at -$79.84 in Q2 2020.
- A 5-year average of -$19.9 and a median of -$11.08 in 2020 frame the typical range for Times Interest Earned.
- The sharpest annual moves came in 2022 and 2023: Times Interest Earned jumped 2949.22% in 2022, then sank 414.76% in 2023.
- A 5-year view of Times Interest Earned shows it stood at -$37.52 in 2019, then jumped by 70.48% to -$11.08 in 2020, then soared by 151.78% to $5.74 in 2021, then slumped by 283.55% to -$10.53 in 2022, then increased by 2.51% to -$10.26 in 2023.
- Business Quant data shows RNAC's Times Interest Earned at -$10.26 in Q3 2023, -$24.78 in Q2 2023, and -$22.75 in Q1 2023.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Times Interest Earned (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 3.58 |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | 11.50 |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | -258.33 |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | 547.67 |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | - |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | 11.79 |
| 10 | Cartesian Therapeutics | 261.84 Mn | 261.84 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2023 | -10.26 |
| Jun 30, 2023 | -24.78 |
| Mar 31, 2023 | -22.75 |
| Dec 31, 2022 | -10.53 |
| Sep 30, 2022 | -1.99 |
| Jun 30, 2022 | 19.38 |
| Mar 31, 2022 | 15.24 |
| Dec 31, 2021 | 5.74 |
| Sep 30, 2021 | -2.77 |
| Jun 30, 2021 | 0.64 |
| Mar 31, 2021 | -10.07 |
| Dec 31, 2020 | -11.08 |
| Sep 30, 2020 | -37.63 |
| Jun 30, 2020 | -79.84 |
| Mar 31, 2020 | -68.95 |
| Dec 31, 2019 | -37.52 |
| Sep 30, 2019 | -30.40 |
| Jun 30, 2019 | -40.59 |
| Mar 31, 2019 | -29.94 |
| Dec 31, 2018 | 2,416.50 |